CORT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 20.70%

Insider Buying (Last 12 Months): $3,314,000.00

Insider Selling (Last 12 Months): $94,065,812.11

Corcept Therapeutics Insider Trading History Chart

Corcept Therapeutics Share Price & Price History

^$110.29

▼ -4.57 (-3.98%)

As of 09/18/2026 04:00 PM ET

Days: 30 | 90 | 365

Corcept Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/16/2026	Roberto Wandenkolk Vieira	Insider	Sell	296	$100.82	$29,842.72	3,946
9/15/2026	James N. Wilson	Director	Sell	10,000	$110.69	$1,106,900.00	1,064,543
9/14/2026	Joseph Douglas Lyon	Insider	Sell	10,000	$113.49	$1,134,900.00	5,683
9/2/2026	Roberto Wandenkolk Vieira	Insider	Sell	58,333	$110.76	$6,460,963.08	4,242
9/1/2026	Sean Maduck	Insider	Sell	25,000	$114.43	$2,860,750.00	9,755
8/26/2026	Kimberly Park	Director	Sell	26,685	$122.55	$3,270,246.75	30,000
8/25/2026	Sean Maduck	Insider	Sell	30,955	$125.58	$3,887,328.90	9,755
8/18/2026	David L. Mahoney	Director	Sell	103,606	$118.25	$12,251,409.50	1,133,539
8/14/2026	James N. Wilson	Director	Sell	10,000	$111.43	$1,114,300.00	1,074,543
8/14/2026	Sean Maduck	Insider	Sell	3,664	$114.49	$419,491.36	9,755
8/10/2026	Sean Maduck	Insider	Sell	1,031	$114.52	$118,070.12	9,755
8/10/2026	William Guyer	Insider	Sell	16,300	$113.43	$1,848,909.00	3,985
8/4/2026	William Guyer	Insider	Sell	3,700	$113.12	$418,544.00	3,985
8/3/2026	Joseph Douglas Lyon	Insider	Sell	1,540	$114.16	$175,806.40	5,495
8/3/2026	Sean Maduck	Insider	Sell	20,305	$114.70	$2,328,983.50	9,755
7/30/2026	Atabak Mokari	CFO	Sell	80,000	$114.71	$9,176,800.00	16,130
7/7/2026	William Guyer	Insider	Sell	20,000	$93.13	$1,862,600.00	3,985
7/1/2026	Sean Maduck	Insider	Sell	25,000	$88.35	$2,208,750.00	9,755
6/17/2026	David L. Mahoney	Director	Sell	20,000	$84.53	$1,690,600.00	26,147
6/16/2026	James N. Wilson	Director	Sell	10,000	$83.20	$832,000.00	1,094,543
6/15/2026	Atabak Mokari	CFO	Sell	40,000	$81.15	$3,246,000.00	16,130
6/2/2026	William Guyer	Insider	Sell	20,000	$70.60	$1,412,000.00	3,985
6/1/2026	Atabak Mokari	CFO	Sell	40,000	$70.00	$2,800,000.00	15,257
6/1/2026	Sean Maduck	Insider	Sell	25,000	$70.21	$1,755,250.00	8,977
5/27/2026	Joseph Douglas Lyon	Insider	Sell	5,000	$65.00	$325,000.00	6,230
5/27/2026	Sean Maduck	Insider	Sell	75,000	$65.59	$4,919,250.00	8,977
5/5/2026	William Guyer	Insider	Sell	20,000	$51.83	$1,036,600.00	2,231
4/7/2026	William Guyer	Insider	Sell	20,000	$40.97	$819,400.00	2,231
3/25/2026	Joseph K. Belanoff	CEO	Sell	26,198	$50.07	$1,311,733.86	2,918,326
3/20/2026	William Guyer	Insider	Sell	11,767	$36.01	$423,729.67	2,231
3/17/2026	G Leonard Baker Jr	Director	Buy	100,000	$33.14	$3,314,000.00	1,146,631
3/4/2026	William Guyer	Insider	Sell	8,233	$35.99	$296,305.67	2,231
2/3/2026	William Guyer	Insider	Sell	20,000	$40.87	$817,400.00	1,235
1/6/2026	William Guyer	Insider	Sell	20,000	$35.18	$703,600.00	1,235
12/2/2025	William Guyer	Insider	Sell	20,000	$80.08	$1,601,600.00	1,235
12/1/2025	Joseph Douglas Lyon	Insider	Sell	5,000	$79.53	$397,650.00	10,277
12/1/2025	Joseph K. Belanoff	CEO	Sell	40,000	$79.77	$3,190,800.00	2,701,370
12/1/2025	Sean Maduck	Insider	Sell	20,000	$79.52	$1,590,400.00	7,904
11/25/2025	William Guyer	Insider	Sell	4,500	$80.90	$364,050.00	787
11/5/2025	Joseph K. Belanoff	CEO	Sell	28,782	$74.77	$2,152,030.14	2,741,370
11/5/2025	William Guyer	Insider	Sell	20,000	$75.36	$1,507,200.00	5,287
11/3/2025	Joseph Douglas Lyon	Insider	Sell	5,000	$73.65	$368,250.00	10,277
11/3/2025	Joseph K. Belanoff	CEO	Sell	11,218	$74.08	$831,029.44	2,770,152
11/3/2025	Sean Maduck	Insider	Sell	20,000	$73.99	$1,479,800.00	7,904
10/10/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$87.54	$192,588.00
10/7/2025	William Guyer	Insider	Sell	20,000	$89.94	$1,798,800.00	5,287
10/1/2025	Joseph Douglas Lyon	Insider	Sell	5,000	$84.75	$423,750.00	10,277
10/1/2025	Joseph K. Belanoff	CEO	Sell	40,000	$85.08	$3,403,200.00	2,781,370
10/1/2025	Sean Maduck	Insider	Sell	20,000	$85.06	$1,701,200.00	7,904
9/10/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$72.45	$159,390.00
9/2/2025	Joseph Douglas Lyon	Insider	Sell	5,000	$70.25	$351,250.00	10,066
9/2/2025	Joseph K. Belanoff	CEO	Sell	40,000	$70.53	$2,821,200.00	2,821,370
9/2/2025	Sean Maduck	Insider	Sell	20,000	$70.49	$1,409,800.00	7,681
9/2/2025	William Guyer	Insider	Sell	20,000	$70.49	$1,409,800.00	5,487
8/11/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$72.30	$159,060.00
8/8/2025	William Guyer	Insider	Sell	35,007	$71.77	$2,512,452.39	5,487
8/5/2025	William Guyer	Insider	Sell	14	$71.77	$1,004.78	5,487
8/1/2025	Joseph Douglas Lyon	Insider	Sell	5,823	$67.51	$393,110.73	10,066
8/1/2025	Joseph K. Belanoff	CEO	Sell	40,000	$68.53	$2,741,200.00	2,861,370
8/1/2025	Sean Maduck	Insider	Sell	35,007	$67.79	$2,373,124.53	7,681
7/18/2025	Joseph Douglas Lyon	Insider	Sell	200	$73.40	$14,680.00	10,066
7/18/2025	Sean Maduck	Insider	Sell	473	$73.44	$34,737.12	17,705
7/18/2025	William Guyer	Insider	Sell	500	$73.44	$36,720.00	5,487
7/17/2025	Joseph Douglas Lyon	Insider	Sell	3,877	$73.48	$284,881.96	10,066
7/17/2025	Joseph K. Belanoff	CEO	Sell	615	$73.69	$45,319.35	2,901,370
7/17/2025	Sean Maduck	Insider	Sell	4,315	$73.48	$317,066.20	17,705
7/17/2025	William Guyer	Insider	Sell	4,379	$73.48	$321,768.92	5,487
7/10/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$71.08	$156,376.00
7/1/2025	Joseph Douglas Lyon	Insider	Sell	100	$73.50	$7,350.00	10,066
7/1/2025	Sean Maduck	Insider	Sell	205	$73.45	$15,057.25	17,705
7/1/2025	William Guyer	Insider	Sell	100	$73.50	$7,350.00	5,487
6/10/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$70.61	$155,342.00
6/10/2025	William Guyer	Insider	Sell	20,000	$72.42	$1,448,400.00	5,487
6/2/2025	Joseph Douglas Lyon	Insider	Sell	5,000	$78.04	$390,200.00	9,009
6/2/2025	Joseph K. Belanoff	CEO	Sell	40,000	$82.86	$3,314,400.00	2,901,985
6/2/2025	Sean Maduck	Insider	Sell	20,000	$79.08	$1,581,600.00	17,705
5/16/2025	David L. Mahoney	Director	Sell	27,352	$74.23	$2,030,338.96
5/16/2025	William Guyer	Insider	Sell	32,262	$74.17	$2,392,872.54	5,487
5/12/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$72.06	$158,532.00
5/6/2025	William Guyer	Insider	Sell	7,060	$74.31	$524,628.60	5,487
5/2/2025	Joseph K. Belanoff	CEO	Sell	40,000	$72.90	$2,916,000.00	2,941,985
5/2/2025	Sean Maduck	Insider	Sell	26,554	$72.23	$1,917,995.42	85,622
4/10/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$70.22	$154,484.00
3/31/2025	Joseph K. Belanoff	CEO	Sell	35,102	$94.72	$3,324,861.44	2,982,335
3/31/2025	Sean Maduck	Insider	Sell	100,000	$100.54	$10,054,000.00	85,622
3/24/2025	Joseph Douglas Lyon	Insider	Sell	421	$60.58	$25,504.18	9,009
3/24/2025	Joseph K. Belanoff	CEO	Sell	1,974	$60.83	$120,078.42	3,017,437
3/3/2025	Joseph K. Belanoff	CEO	Sell	2,924	$60.91	$178,100.84	3,019,411
3/3/2025	Sean Maduck	Insider	Sell	18,303	$60.69	$1,110,809.07	85,622
2/10/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$68.08	$149,776.00
1/10/2025	Daniel N. Swisher, Jr.	Director	Sell	2,200	$50.54	$111,188.00
1/2/2025	Sean Maduck	Insider	Sell	20,000	$50.39	$1,007,800.00	85,318
12/10/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$59.46	$130,812.00
11/22/2024	Joseph Douglas Lyon	Insider	Sell	1,411	$56.72	$80,031.92	8,494
11/11/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$59.88	$131,736.00
11/4/2024	William Guyer	Insider	Sell	3,394	$48.97	$166,204.18	5,796
11/1/2024	William Guyer	Insider	Sell	6,606	$48.97	$323,495.82	5,796
10/1/2024	Gary Charles Robb	Insider	Sell	11,000	$46.28	$509,080.00	22,772
9/3/2024	William Guyer	Insider	Sell	10,000	$35.30	$353,000.00	6,039
8/26/2024	Gary Charles Robb	Insider	Sell	3,101	$35.71	$110,736.71	23,190
8/1/2024	Daniel N. Swisher, Jr.	Director	Sell	150	$38.50	$5,775.00
8/1/2024	William Guyer	Insider	Sell	10,000	$38.67	$386,700.00	6,039
7/1/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$32.81	$72,182.00
7/1/2024	Joseph Douglas Lyon	Insider	Sell	5,000	$32.49	$162,450.00	9,290
6/3/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$30.21	$66,462.00
6/3/2024	Joseph Douglas Lyon	Insider	Sell	5,000	$30.18	$150,900.00	7,314
5/28/2024	Gary Charles Robb	Insider	Sell	11,000	$30.39	$334,290.00	20,203
5/13/2024	Sean Maduck	Insider	Sell	50,000	$28.00	$1,400,000.00	85,222
5/9/2024	Joseph Douglas Lyon	Insider	Sell	7,227	$26.00	$187,902.00	7,314
5/2/2024	Joseph Douglas Lyon	Insider	Sell	10,830	$26.00	$281,580.00	7,314
4/4/2024	Joseph Douglas Lyon	Insider	Sell	5,443	$26.00	$141,518.00	7,314
4/1/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$25.30	$55,660.00
4/1/2024	Joseph Douglas Lyon	Insider	Sell	500	$26.01	$13,005.00	7,314
3/27/2024	Sean Maduck	Insider	Sell	25,953	$25.01	$649,084.53	85,222
3/18/2024	Sean Maduck	Insider	Sell	17,219	$25.00	$430,475.00	75,222
3/1/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$23.59	$51,898.00
2/16/2024	Joseph Douglas Lyon	CAO	Sell	1,000	$26.00	$26,000.00	6,774
2/16/2024	Sean Maduck	Insider	Sell	27,068	$25.97	$702,955.96	74,455
2/1/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$22.00	$48,400.00
1/2/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$22.11	$48,642.00
12/22/2023	William Guyer	Insider	Sell	10,000	$32.00	$320,000.00	6,643
12/5/2023	Gary Charles Robb	Insider	Sell	1,381	$26.27	$36,278.87	27,602
12/4/2023	Joseph Douglas Lyon	CAO	Sell	2,432	$26.00	$63,232.00	5,854
12/1/2023	Daniel N. Swisher, Jr.	Director	Sell	2,200	$25.47	$56,034.00
12/1/2023	Joseph Douglas Lyon	CAO	Sell	2,568	$26.00	$66,768.00	5,854
12/1/2023	Sean Maduck	Insider	Sell	25,000	$25.56	$639,000.00	73,291
11/2/2023	Joseph Douglas Lyon	CAO	Sell	3,977	$28.11	$111,793.47	5,854
11/1/2023	Daniel N. Swisher, Jr.	Director	Sell	2,200	$27.96	$61,512.00
11/1/2023	Sean Maduck	Insider	Sell	5,112	$28.08	$143,544.96	73,291
10/10/2023	Sean Maduck	Insider	Sell	18,471	$27.29	$504,073.59	73,291
10/6/2023	Joseph Douglas Lyon	CAO	Sell	2,582	$27.24	$70,333.68	5,854
10/6/2023	Sean Maduck	Insider	Sell	3,498	$27.24	$95,285.52	73,610
10/2/2023	Daniel N. Swisher, Jr.	Director	Sell	2,200	$27.32	$60,104.00
10/2/2023	Joseph Douglas Lyon	CAO	Sell	2,418	$27.25	$65,890.50	5,854
10/2/2023	Sean Maduck	Insider	Sell	3,031	$27.24	$82,564.44	73,610
9/19/2023	Sean Maduck	Insider	Sell	25,000	$32.48	$812,000.00	73,610

SEC Filings (Institutional Ownership Changes) for Corcept Therapeutics (NASDAQ:CORT)

93.61% of Corcept Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Corcept Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/9/2026	Sequoia Financial Advisors LLC	7,423	$0.65M	0.0%	N/A	0.007%
9/9/2026	Tidal Investments LLC	24,218	$2.11M	0.0%	+9.2%	0.022%
9/9/2026	Engineers Gate Manager LP	3,683	$0.32M	0.0%	-81.1%	0.003%
9/9/2026	Integrated Wealth Concepts LLC	6,423	$0.56M	0.0%	N/A	0.006%
9/9/2026	NewEdge Advisors LLC	11,041	$0.96M	0.0%	+17.9%	0.010%
9/9/2026	IFP Advisors Inc	909	$79K	0.0%	+568.4%	0.001%
9/8/2026	Allworth Financial LP	3,892	$0.34M	0.0%	+151.1%	0.004%
9/8/2026	Arizona State Retirement System	26,417	$2.30M	0.0%	+1.6%	0.024%
9/8/2026	Waverly Advisors LLC	3,516	$0.31M	0.0%	N/A	0.003%
9/8/2026	Nykredit A S	3,205	$0.28M	0.0%	N/A	0.003%
8/27/2026	Corient Private Wealth LP	12,198	$1.06M	0.0%	+108.4%	0.011%
8/26/2026	Amundi	9,751	$0.85M	0.0%	-14.4%	0.009%
8/26/2026	HighTower Advisors LLC	10,106	$0.88M	0.0%	-15.3%	0.009%
8/25/2026	VIRGINIA RETIREMENT SYSTEMS ET Al	26,574	$2.31M	0.0%	N/A	0.025%
8/23/2026	Wedmont Private Capital	3,139	$0.29M	0.0%	N/A	0.003%
8/23/2026	HB Wealth Management LLC	5,186	$0.45M	0.0%	N/A	0.005%
8/22/2026	denkapparat Operations GmbH	2,360	$0.21M	0.1%	N/A	0.002%
8/22/2026	Concurrent Investment Advisors LLC	13,380	$1.16M	0.0%	+65.2%	0.012%
8/21/2026	Nykredit A S	3,205	$0.28M	0.0%	N/A	0.003%
8/20/2026	Two Sigma Securities LLC	2,959	$0.26M	0.0%	N/A	0.003%
8/19/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	202,743	$17.63M	0.0%	-6.8%	0.188%
8/19/2026	Van ECK Associates Corp	139,135	$12.10M	0.0%	-12.8%	0.129%
8/19/2026	Hsbc Holdings PLC	15,623	$1.38M	0.0%	+134.8%	0.014%
8/18/2026	Empowered Funds LLC	3,341	$0.29M	0.0%	N/A	0.003%
8/18/2026	Public Employees Retirement System of Ohio	27,596	$2.40M	0.0%	N/A	0.026%
8/17/2026	Capstone Investment Advisors LLC	2,726	$0.24M	0.0%	N/A	0.003%
8/17/2026	Transamerica Financial Advisors LLC	1,789	$0.16M	0.0%	N/A	0.002%
8/17/2026	Corient Private Wealth LP	6,541	$0.57M	0.0%	N/A	0.006%
8/17/2026	Bank of America Corp DE	328,565	$28.57M	0.0%	N/A	0.304%
8/15/2026	Freestone Grove Partners LP	995	$87K	0.0%	N/A	0.001%
8/15/2026	Odyssean LLC	14,271	$1.24M	0.2%	N/A	0.013%
8/15/2026	Man Group plc	71,491	$6.22M	0.0%	N/A	0.066%
8/15/2026	Jupiter Topco LLC	138,743	$12.06M	0.0%	N/A	0.128%
8/14/2026	Hsbc Holdings PLC	15,623	$1.38M	0.0%	N/A	0.014%
8/14/2026	Canada Pension Plan Investment Board	191,101	$16.62M	0.0%	N/A	0.177%
8/14/2026	Legal & General Group Plc	218,078	$18.96M	0.0%	N/A	0.202%
8/14/2026	The Manufacturers Life Insurance Company	30,914	$2.69M	0.0%	N/A	0.029%
8/14/2026	Algert Global LLC	38,040	$3.31M	0.0%	N/A	0.035%
8/13/2026	OMERS ADMINISTRATION Corp	30,700	$2.67M	0.0%	N/A	0.028%
8/13/2026	Sanctuary Advisors LLC	9,289	$0.81M	0.0%	N/A	0.009%
8/13/2026	Connor Clark & Lunn Investment Management Ltd.	81,569	$7.09M	0.0%	N/A	0.075%
8/12/2026	Evolve Private Wealth LLC	2,603	$0.23M	0.0%	N/A	0.002%
8/12/2026	Westpac Banking Corp	1,583	$0.14M	0.0%	N/A	0.001%
8/12/2026	EP Wealth Advisors LLC	4,850	$0.42M	0.0%	N/A	0.004%
8/12/2026	Ieq Capital LLC	92,394	$8.03M	0.0%	N/A	0.085%
8/11/2026	Allworth Financial LP	3,892	$0.34M	0.0%	N/A	0.004%
8/11/2026	Vise Technologies Inc.	9,366	$0.81M	0.0%	N/A	0.009%
8/11/2026	Lisanti Capital Growth LLC	91,610	$7.97M	1.8%	N/A	0.085%
8/10/2026	NewEdge Wealth LLC	34,890	$3.03M	0.0%	N/A	0.032%
8/7/2026	Citizens Financial Group Inc. RI	3,997	$0.35M	0.0%	N/A	0.004%
8/7/2026	Texas Capital Bank Wealth Management Services Inc	3,527	$0.31M	0.0%	N/A	0.003%
8/7/2026	BlackRock Inc.	12,432,023	$1.08B	0.0%	N/A	11.500%
8/7/2026	Pallas Capital Advisors LLC	5,918	$0.52M	0.0%	N/A	0.005%
8/7/2026	Deutsche Bank AG	11,106	$0.97M	0.0%	N/A	0.010%
8/7/2026	Mitsubishi UFJ Asset Management Co. Ltd.	313	$27K	0.0%	N/A	0.000%
8/6/2026	Alberta Investment Management Corp	113,200	$9.84M	0.1%	N/A	0.105%
8/6/2026	Bank of New York Mellon Corp	565,666	$49.19M	0.0%	N/A	0.523%
8/6/2026	Focus Partners Advisor Solutions LLC	6,677	$0.58M	0.0%	N/A	0.006%
8/6/2026	GSA Capital Partners LLP	23,257	$2.02M	0.1%	N/A	0.022%
7/10/2026	Handelsbanken Fonder AB	36,881	$3.21M	0.0%	+28.1%	0.034%
7/9/2026	Hennion & Walsh Asset Management Inc.	45,429	$3.95M	0.1%	-1.2%	0.042%
7/9/2026	Breakwater Capital Group	2,832	$0.25M	0.0%	N/A	0.003%
7/8/2026	Evanson Financial LLC	12,478	$1.09M	0.1%	N/A	0.012%
7/7/2026	GAMMA Investing LLC	4,640	$0.40M	0.0%	+54.0%	0.004%
6/18/2026	Pacer Advisors Inc.	3,184	$0.13M	0.0%	+56.8%	0.003%
6/10/2026	FAS Wealth Partners Inc.	322,370	$13M	0.8%	+4.0%	0.300%
6/3/2026	Parallel Advisors LLC	3,977,404	$160.33M	2.9%	+2.5%	3.705%
6/3/2026	NewEdge Advisors LLC	9,364	$0.38M	0.0%	+727.2%	0.009%
5/29/2026	Perceptive Advisors LLC	50,000	$2.02M	0.0%	N/A	0.047%
5/28/2026	Avidity Partners Management LP	30,000	$1.21M	0.2%	+36.4%	0.028%
5/19/2026	Bank of America Corp DE	111,736	$4.50M	0.0%	+33.6%	0.104%
5/19/2026	Tanaka Capital Management Inc.	110,854	$4.47M	5.3%	-0.2%	0.103%
5/19/2026	Edgestream Partners L.P.	69,217	$2.79M	0.1%	N/A	0.064%
5/19/2026	Janus Henderson Group PLC	164,074	$6.61M	0.0%	+7.1%	0.153%
5/18/2026	ADAR1 Capital Management LLC	8,000	$0.32M	0.0%	N/A	0.007%
5/18/2026	Amundi	11,392	$0.46M	0.0%	N/A	0.011%
5/18/2026	Gould Capital LLC	1,000	$40K	0.0%	+66.7%	0.001%
5/18/2026	California State Teachers Retirement System	110,829	$4.47M	0.0%	+23.1%	0.103%
5/18/2026	Royal Bank of Canada	14,314	$0.58M	0.0%	+13.7%	0.013%
5/18/2026	Empowered Funds LLC	97,295	$3.92M	0.0%	N/A	0.091%
5/16/2026	The Manufacturers Life Insurance Company	24,158	$0.97M	0.0%	+9.1%	0.023%
5/16/2026	Quantinno Capital Management LP	28,854	$1.16M	0.0%	+2.6%	0.027%
5/16/2026	Lazard Asset Management LLC	8,279	$0.33M	0.0%	+18.2%	0.008%
5/15/2026	OMERS ADMINISTRATION Corp	27,200	$1.10M	0.0%	N/A	0.025%
5/15/2026	Affinity Asset Advisors LLC	50,000	$2.02M	0.1%	N/A	0.047%
5/15/2026	Entropy Technologies LP	16,499	$0.67M	0.0%	N/A	0.015%
5/14/2026	Renaissance Technologies LLC	5,682,783	$229.07M	0.4%	-1.3%	5.294%
5/14/2026	Public Employees Retirement System of Ohio	27,831	$1.12M	0.0%	-2.8%	0.026%
5/14/2026	Arrowstreet Capital Limited Partnership	67,972	$2.74M	0.0%	-54.6%	0.063%
5/14/2026	Inceptionr LLC	8,612	$0.35M	0.1%	N/A	0.008%
5/14/2026	Sei Investments Co.	32,379	$1.31M	0.0%	-65.8%	0.030%
5/14/2026	State of Wyoming	816	$33K	0.0%	+29.5%	0.001%
5/13/2026	NewEdge Wealth LLC	27,887	$1.12M	0.0%	+234.3%	0.026%
5/13/2026	First Citizens Bank & Trust Co.	10,803	$0.44M	0.0%	-6.0%	0.010%
5/13/2026	First Trust Advisors LP	2,173,376	$87.61M	0.1%	+213.5%	2.025%
5/8/2026	PNC Financial Services Group Inc.	19,030	$0.77M	0.0%	+8.3%	0.018%
5/7/2026	Dimensional Fund Advisors LP	1,553,135	$62.60M	0.0%	-4.1%	1.447%
5/7/2026	Parallel Advisors LLC	3,977,404	$160.33M	2.8%	+2.5%	3.705%
5/7/2026	KBC Group NV	94,767	$3.82M	0.0%	+1,684.4%	0.088%
5/6/2026	Assetmark Inc.	79,943	$3.22M	0.0%	-2.6%	0.074%

Data available starting January 2016

Corcept Therapeutics Incorporated engages in discovery and development of drugs for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. It offers Korlym tablets medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous cushing's syndrome; and who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. The company is also developing relacorilant, which is in phase III clinical trial for the treatment of cushing's syndrome; treatment for adrenal cancer and cortisol excess which is in phase 1b clinical trial; treatment for prostate cancer which is in phase II clinical trial; and nab-paclitaxel in combination with relacorilant, which is in phase III clinical trial to treat platinum-resistant ovarian tumors. In addition, it develops dazucorilant, which is in phase II clinical trial for the treatment of amyotrophic lateral sclerosis; miricorilant, which is in phase IIb trial for the treatment of nonalcoholic steatohepatitis; and treatment for antipsychotic induced weight gain that is in phase I trial. The company was incorporated in 1998 and is headquartered in Menlo Park, California.

Today's Range

Now: $110.29

$108.41

$117.90

50 Day Range

MA: $108.56

$85.90

$123.57

52 Week Range

Now: $110.29

$28.66

$126.38

Volume

17,233,207 shs

Average Volume

847,143 shs

Market Capitalization

$11.92 billion

P/E Ratio

262.60

Dividend Yield

N/A

Beta

0.45

Who are the company insiders with the largest holdings of Corcept Therapeutics?: Corcept Therapeutics' top insider investors include:
Joseph K Belanoff (CEO)
Joseph K Belanoff (Insider)
Joseph Cook, Jr (Director)
G Leonard Baker Jr (Director)
David L Mahoney (Director)
James N Wilson (Director)
G Leonard Baker, Jr (Director)
Patrick G Enright (Director)
Gary Charles Robb (CFO)
Gary Charles Robb (Insider)
Learn More about top insider investors at Corcept Therapeutics.
Who are the major institutional investors of Corcept Therapeutics?: Corcept Therapeutics' top institutional shareholders include:
BlackRock Inc. — 11.50%
Bank of New York Mellon Corp — 0.52%
Bank of America Corp DE — 0.30%
Legal & General Group Plc — 0.20%
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 0.19%
Canada Pension Plan Investment Board — 0.18%
Learn More about top institutional investors of Corcept Therapeutics stock.
Which institutional investors are selling Corcept Therapeutics stock?: During the last quarter, CORT stock was sold by these institutional investors:
Van ECK Associates Corp
Engineers Gate Manager LP
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
HighTower Advisors LLC
Amundi
Hennion & Walsh Asset Management Inc.
California State Teachers Retirement System
During the previous year, company insiders that have sold Corcept Therapeutics company stock include:
Joseph K Belanoff (CEO)
David L Mahoney (Director)
James N Wilson (Director)
Kimberly Park (Director)
Atabak Mokari (CFO)
Joseph Douglas Lyon (Insider)
Sean Maduck (Insider)
William Guyer (Insider)
Roberto Wandenkolk Vieira (Insider)
Daniel N Swisher Jr (Director)
Learn More investors selling Corcept Therapeutics stock.
Which institutional investors are buying Corcept Therapeutics stock?: In the previous quarter, CORT stock was bought by institutional investors including:
BlackRock Inc.
Bank of New York Mellon Corp
Bank of America Corp DE
Legal & General Group Plc
Canada Pension Plan Investment Board
Jupiter Topco LLC
Alberta Investment Management Corp
Ieq Capital LLC